Your browser doesn't support javascript.
loading
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Bikdeli, Behnood; Talasaz, Azita H; Rashidi, Farid; Sharif-Kashani, Babak; Farrokhpour, Mohsen; Bakhshandeh, Hooman; Sezavar, Hashem; Dabbagh, Ali; Beigmohammadi, Mohammad Taghi; Payandemehr, Pooya; Yadollahzadeh, Mahdi; Riahi, Taghi; Khalili, Hossein; Jamalkhani, Sepehr; Rezaeifar, Parisa; Abedini, Atefeh; Lookzadeh, Somayeh; Shahmirzaei, Shaghayegh; Tahamtan, Ouria; Matin, Samira; Amin, Ahmad; Parhizgar, Seyed Ehsan; Jimenez, David; Gupta, Aakriti; Madhavan, Mahesh V; Parikh, Sahil A; Monreal, Manuel; Hadavand, Naser; Hajighasemi, Alireza; Maleki, Majid; Sadeghian, Saeed; Mohebbi, Bahram; Piazza, Gregory; Kirtane, Ajay J; Lip, Gregory Y H; Krumholz, Harlan M; Goldhaber, Samuel Z; Sadeghipour, Parham.
Afiliación
  • Bikdeli B; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, CT, USA; Cardiovascular Research Foundation (CRF), New York, NY, USA. Electronic address: bbikdeli@bwh.harvard.edu.
  • Talasaz AH; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Rashidi F; Tuberclosis and Lung Diseases Research Center, Tabriz, Iran.
  • Sharif-Kashani B; Tobacoo Prevention and control Research center, National Research lnstitute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran; Lung Transplantion Research Center, Department of Cardiology, National Research Institute of Tuberculosls and Lung Dis
  • Farrokhpour M; Firouzgar Hospital, Department of Internal Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Bakhshandeh H; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
  • Sezavar H; Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Dabbagh A; Department of Anesthesiology, School of Medicine Anesthesiology Research Center Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Beigmohammadi MT; Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Payandemehr P; Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Yadollahzadeh M; Firouzgar Hospital, Department of Internal Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Riahi T; Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Khalili H; Department of Pharmacotherapy, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Jamalkhani S; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran; Aalborg University, Aalborg, Denmark.
  • Rezaeifar P; Tuberclosis and Lung Diseases Research Center, Tabriz, Iran.
  • Abedini A; Chronic Respiratory Disease Research Center, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Lookzadeh S; Chronic Respiratory Disease Research Center, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shahmirzaei S; Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Tahamtan O; Tuberclosis and Lung Diseases Research Center, Tabriz, Iran.
  • Matin S; Tuberclosis and Lung Diseases Research Center, Tabriz, Iran.
  • Amin A; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
  • Parhizgar SE; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
  • Jimenez D; Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain; Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain; CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain.
  • Gupta A; Cardiovascular Research Foundation (CRF), New York, NY, USA; Division of Cardiology, Columbia University Irving Medical Center, New York, NY, USA.
  • Madhavan MV; Cardiovascular Research Foundation (CRF), New York, NY, USA; Division of Cardiology, Columbia University Irving Medical Center, New York, NY, USA.
  • Parikh SA; Cardiovascular Research Foundation (CRF), New York, NY, USA; Division of Cardiology, Columbia University Irving Medical Center, New York, NY, USA.
  • Monreal M; Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Universidad Católica de Murcia, Murcia, Spain.
  • Hadavand N; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
  • Hajighasemi A; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Maleki M; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
  • Sadeghian S; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohebbi B; Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran.
  • Piazza G; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Kirtane AJ; Cardiovascular Research Foundation (CRF), New York, NY, USA; Division of Cardiology, Columbia University Irving Medical Center, New York, NY, USA.
  • Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Aalborg University, Aalborg, Denmark.
  • Krumholz HM; Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, CT, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Health Policy and Adminitration, Yale School of Public Health, New Haven, CT, USA.
  • Goldhaber SZ; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Sadeghipour P; Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Iran; Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Iran. Electronic address: psadeghipour@hotmail
Thromb Res ; 196: 382-394, 2020 12.
Article en En | MEDLINE | ID: mdl-32992075
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_cardiovascular_diseases / 6_other_respiratory_diseases / 6_venous_thromboembolic_disease Asunto principal: Trombosis / Enoxaparina / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Tromboembolia Venosa / Atorvastatina / Tratamiento Farmacológico de COVID-19 / Anticoagulantes Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Thromb Res Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_cardiovascular_diseases / 6_other_respiratory_diseases / 6_venous_thromboembolic_disease Asunto principal: Trombosis / Enoxaparina / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Tromboembolia Venosa / Atorvastatina / Tratamiento Farmacológico de COVID-19 / Anticoagulantes Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Thromb Res Año: 2020 Tipo del documento: Article